China Resources Pharmaceutical Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
11,451.00
10,456.00
9,467.00
8,094.00
6,868.00
6,499.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
3,072.00
1,769.00
-934.00
300.00
-3,762.00
-2,011.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
17,547.00
15,007.00
10,898.00
11,220.00
6,277.00
5,254.00
Cash Flow from Investing Activities
-5,114.00
640.00
-3,298.00
-8,832.00
-2,021.00
1,041.00
Cash Flow from Financing Activities
-18,326.00
-5,581.00
-9,001.00
5,313.00
-3,601.00
-9,103.00
Net Cash Inflow / Outflow
-5,931.00
10,077.00
-1,830.00
7,338.00
-199.00
-3,035.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-38.00
10.00
-429.00
-362.00
-853.00
-228.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of China Resources Pharmaceutical Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
11451.4724759382
23267.6192585317
-11,816.00
-50.78%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
3072.12223636406
-2037.69794697523
5,109.00
250.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
17547.7042642487
19100.7698468215
-1,553.00
-8.13%
Cash Flow from Investing Activities
-5114.3944559253
-1116.84758978972
-3,998.00
-357.93%
Cash Flow from Financing Activities
-18326.6204307185
172.802531274508
-18,498.00
-10705.53%
Net Cash Inflow / Outflow
-5931.49698612806
17754.9381615835
-23,685.00
-133.41%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-38.1863637330058
-401.786626722696
363.00
90.50%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 16.92% vs 37.70% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
17,547.70
15,007.69
16.92%






